Showing results (781-790 of 809) with videos related to
Sort By:
Pageof 81
European Journal of Cancer (Oxford, England : 1990)|October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trialShan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.BMC Cancer|August 12, 2014
Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinomaWen-Hui Chen, Lin-Quan Tang, Feng-Wei Wang, et al.BMC Cancer|December 18, 2015
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapyShan-Shan Guo, Lin-Quan Tang, Lu Zhang, et al.International Journal of Radiation Oncology, Biology, Physics|December 9, 2014
High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort studyLin-Quan Tang, Chao-Feng Li, Qiu-Yan Chen, et al.BMC Cancer|February 2, 2018
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRTShan-Shan Guo, Wen Hu, Qiu-Yan Chen, et al.Oncotarget|April 23, 2016
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched studyShan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, et al.Journal of Cancer|November 19, 2019
The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysisYue-Feng Wen, Xue-Song Sun, Li Yuan, et al.Cell Research|September 9, 2020
Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinomaShanzhao Jin, Ruoyan Li, Ming-Yuan Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority TrialXiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial stagingLin-Quan Tang, Qiu-Yan Chen, Wei Fan, et al.Pageof 81